Amanta Healthcare IPO: GMP, Price Band, Lot Size, Allotment, Listing & More
Stay tuned with IPO Ji for regular updates on Amanta Healthcare IPO GMP, subscription status, allotment, refund, and listing performance.
The Amanta Healthcare IPO is all set to open for subscription on September 1, 2025 and will close on September 3, 2025. With a price band fixed between ₹120 and ₹126 per share, investors are keen to know every detail about this issue, from the IPO size, lot size, subscription details, financial performance, competitive strengths, risks, GMP today, allotment dates, and listing expectations. IPO Ji brings you the most comprehensive coverage of the Amanta Healthcare IPO to help retail investors, HNIs, and institutions make an informed decision.
Amanta Healthcare IPO Details
The issue of the Amanta Healthcare IPO is of Rs.126 crore; however, it is restricted to a fresh issue of 1 crore equity shares. The company has fixed face value of the equity shares at 10-rupee each, whereas the price band of the IPO is 120 to 126 per share worth 12x and 12.6x of the face value of the shares respectively.
Retail investors have been allotted a fixed lot size of 119 shares per application meaning that they must invest at least 14,994 at the upper price band. Non-institutional investors (NIIs) can declare various application sizes where the small NIIs (sNII) should apply not less than 14 lots (1,666 shares upon purchase of 2,09,916), but the big NIIs (bNII) are required to apply a minimum of 67 lots (7,973 shares upon investment of 10,04,598).
According to SEBI guidelines, less than or equal to 50 per cent shares of the offer are proposed to be reserved in the category of QIBs, not less than 15 per cent in the Non-Institutional Investor category and not less than 35 per cent of the offer has been earmarked towards retail investors.
Amanta Healthcare IPO Highlights
- IPO Type: Book Built Issue
- IPO Size: ₹126.00 Crore
- Fresh Issue: 1.00 Crore Equity Shares
- Face Value: ₹10 per share
- Price Band: ₹120 – ₹126 per share
- Lot Size: 119 shares per lot
- Minimum Investment (Retail): ₹14,994 (119 shares)
- Listing at: BSE, NSE
- Issue Opens: September 1, 2025
- Issue Closes: September 3, 2025
- Basis of Allotment: September 4, 2025
- Refunds Initiation: September 5, 2025
- Shares Credit to Demat: September 5, 2025
- IPO Listing Date: September 9, 2025 (Tentative)
- Book Running Lead Manager: Beeline Capital Advisors Pvt. Ltd.
- Registrar: MUFG Intime India Pvt. Ltd.
The Amanta Healthcare IPO will open for subscription on September 1, 2025 (Monday) and will close on September 3, 2025 (Wednesday). The allocation to anchor investors is scheduled for August 29, 2025 (Friday).
The basis of allotment will be finalised on September 4, 2025, while refunds will be initiated on September 5, 2025. Shares will also be credited to the demat accounts of successful applicants on the same day. Finally, the Amanta Healthcare IPO listing date is fixed for September 9, 2025 (Tuesday) on both the BSE and NSE.
Amanta Healthcare IPO Price Band and Lot Size
The Amanta Healthcare IPO price band is fixed at ₹120 to ₹126 per share, which is 12x to 12.6x the face value.
- Retail Investor Minimum Investment: ₹14,994 (119 shares at upper band)
- sNII (Small HNI): 14 lots (1,666 shares) = ₹2,09,916
- bNII (Big HNI): 67 lots (7,973 shares) = ₹10,04,598
The reservation is as follows:
- QIBs: Not more than 50%
- NIIs: Not less than 15%
- Retail Investors: Not less than 35%
Use of IPO Proceeds
Amanta Healthcare will use the proceeds of the IPO mainly to increase its manufacturing capacity. Out of the amount, 70 crore will be invested in the commissioning of a new line in SteriPort, at Hariyala, and 30.13 crore to commission a new line in the field of SVP at the same facility. The balance funds will have a general corporate usage which further strengthens the operations of the company.
Amanta Healthcare Limited
Amanta Healthcare Limited was started in December 1994, and it specialises in manufacturing, developing and marketing sterile liquid formulations and medical devices. It is experienced in the production of parenteral products using state-of-the art Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies, guaranteeing sterile, contamination-free fill-seal packaging.
Its products line-up consists of:
- Intravenous fluids (IV)
- Fluid therapy and fluid therapy drug formulations
- Ophthalmic reagents and lubricants
- Respiratory care products
- Depending on the wet soil, irrigation solutions and first-aid medical instruments
Amanta Healthcare has over 45 generic pharmaceutical products marketed under its brands through the strong domestic network of 320 distributors and stockists. On the international level, the company has established an excellent position in 21 countries across Africa, Latin America, the UK and in other countries, and products registered in 19 of these countries as per the regulatory norms.
The business verticals in which the company will operate include National Sales, International Sales and Product Partnering with Indian and foreign pharma companies. On March 31, 2025, Amanta Healthcare had a workforce of 1,718 professionals at its manufacturing plants, formulation development units and quality labs.
Amanta Healthcare Financial Performance
For the fiscal year ending March 31, 2025, Amanta Healthcare reported a revenue of ₹276.09 crore, which was slightly lower compared to ₹281.61 crore in FY24. However, the company witnessed a sharp improvement in profitability. Profit After Tax (PAT) surged by 189% to ₹10.5 crore in FY25, as against ₹3.63 crore in the previous fiscal year.
This indicates that despite muted revenue growth, Amanta Healthcare has managed to significantly improve margins and bottom-line performance through operational efficiency. According to its Red Herring Prospectus (RHP), the company’s only listed peer is Denis Chem Lab Ltd, which currently trades at a P/E ratio of 15.92.
Competitive Strengths
Amanta Healthcare highlights several competitive advantages that position it well in the pharmaceutical space:
- Diversified Product Portfolio – Offering IV fluids, ophthalmic solutions, respiratory care, and medical devices.
- Large Manufacturing Capacity – State-of-the-art facilities using ABFS and ISBM technologies.
- Strong Market Presence – Wide domestic distribution network with global exports to 21 countries.
- Experienced Leadership – Backed by an efficient management team and a skilled workforce.
Amanta Healthcare IPO GMP Today
The Amanta Healthcare IPO Grey Market Premium (GMP) is one of the most tracked indicators for IPO investors. GMP reflects the premium at which Amanta Healthcare shares are being traded in the grey market, ahead of listing. This gives investors an idea of potential listing gains. IPO Ji will update readers daily with the Amanta Healthcare IPO GMP today until listing day.
Allotment and Listing of Amanta Healthcare IPO
The basis of allotment for Amanta Healthcare IPO will be completed on September 4, 2025, followed by refunds and credit of shares on September 5, 2025. The shares are expected to debut on the stock exchanges on September 9, 2025, where they will be listed on both BSE and NSE.
Investors can check their Amanta Healthcare IPO allotment status online through the official portal of the registrar, MUFG Intime India Pvt. Ltd., by entering their PAN, application number, or DP ID.
Frequently Asked Questions (FAQs)
Q1. What is the Amanta Healthcare IPO price band?
The price band of Amanta Healthcare IPO has been set between ₹120 and ₹126 per share.
Q2. What is the minimum lot size for Amanta Healthcare IPO?
The lot size of Amanta Healthcare IPO is 119 shares, requiring a minimum investment of ₹14,994.
Q3. When does the Amanta Healthcare IPO open and close?
The Amanta Healthcare IPO will open on September 1, 2025, and close on September 3, 2025.
Q4. How many shares are offered in the Amanta Healthcare IPO?
The Amanta Healthcare IPO issue consists of a fresh issue of 1 crore equity shares worth ₹126 crore.
Q5. When will the Amanta Healthcare IPO allotment be finalised?
The Amanta Healthcare IPO allotment will be finalised on September 4, 2025.
Q6. What is the Amanta Healthcare IPO listing date?
The Amanta Healthcare IPO is expected to list on BSE and NSE on September 9, 2025.
Q7. Who is managing the Amanta Healthcare IPO?
Beeline Capital Advisors Pvt. Ltd. is the lead manager and MUFG Intime India Pvt. Ltd. is the registrar for Amanta Healthcare IPO.
